Real-World Efficacy of the Dabrafenib-Trametinib (D-T) Combination in Braf V600e-Mutated Metastatic Non-Small Cell Lung Cancer (nsclc): Results from the Ifct-2004 Blade Cohort
LUNG CANCER(2025)
Key words
Non-small-cell lung cancer,BRAF mutation,Targeted therapy,Dabrafenib-trametinib combination,Real-world evidence
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined